130 related articles for article (PubMed ID: 3907638)
1. [Clinical double blind study with the calcium antagonist flunarizine cerebral circulatory disturbances].
Eckmann F
Arzneimittelforschung; 1985; 35(8):1276-9. PubMed ID: 3907638
[TBL] [Abstract][Full Text] [Related]
2. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
[TBL] [Abstract][Full Text] [Related]
3. Randomized double-blind study of flunarizine versus placebo in patients with chronic cerebrovascular disorders.
Agnoli A; Manna V; Martucci N; Fioravanti M; Ferromilone F; Cananzi A; D'Andrea G; De Rosa A; Vizioli R; Sinforiani E
Int J Clin Pharmacol Res; 1988; 8(3):189-97. PubMed ID: 3042644
[TBL] [Abstract][Full Text] [Related]
4. [Flunarizine--a new agent for migraine prevention. Results of a double-blind comparison with placebo].
Frenken CW; Nuijten ST
Fortschr Med; 1984 Mar; 102(12):349-51. PubMed ID: 6370811
[TBL] [Abstract][Full Text] [Related]
5. Calcium antagonists in the prevention of motion sickness.
Lee JA; Watson LA; Boothby G
Aviat Space Environ Med; 1986 Jan; 57(1):45-8. PubMed ID: 3510617
[TBL] [Abstract][Full Text] [Related]
6. Review of placebo-controlled trials with bupropion.
Zung WW
J Clin Psychiatry; 1983 May; 44(5 Pt 2):104-14. PubMed ID: 6406436
[TBL] [Abstract][Full Text] [Related]
7. [Effectiveness of flunarizine in chronic headache. Double-blind study of placebo and amitriptyline].
Canepari C; Riva M; Erminio F
Clin Ter; 1985 Dec; 115(6):463-8. PubMed ID: 3913563
[No Abstract] [Full Text] [Related]
8. [Double-blind clinical study: flunarizine versus pizotifen in a single nightly dose in hemicrania patients].
Cerbo R; Casacchia M; Formisano R; Buzzi MG; Boni B; Feliciani M; Grillo G; Cusimano G; Agnoli A
Riv Neurol; 1985; 55(2):139-46. PubMed ID: 4012191
[TBL] [Abstract][Full Text] [Related]
9. [Activity and acceptability of indalpine in a double-blind study versus placebo].
Gisselmann A
Encephale; 1984; 10(5):231-4. PubMed ID: 6151492
[TBL] [Abstract][Full Text] [Related]
10. Duloxetine in the treatment of Major Depressive Disorder: a comparison of efficacy in patients with and without melancholic features.
Mallinckrodt CH; Watkin JG; Liu C; Wohlreich MM; Raskin J
BMC Psychiatry; 2005 Jan; 5():1. PubMed ID: 15631624
[TBL] [Abstract][Full Text] [Related]
11. Milnacipran and pindolol: a randomized trial of reduction of antidepressant latency.
Isaac MT; Isaac MB; Gallo F; Tournoux A
Hum Psychopharmacol; 2003 Dec; 18(8):595-601. PubMed ID: 14696018
[TBL] [Abstract][Full Text] [Related]
12. Psychopharmacological correlates of post-psychotic depression: a double-blind investigation of haloperidol vs thiothixene in outpatient schizophrenia.
Abuzzahab FS; Zimmerman RL
J Clin Psychiatry; 1982 Mar; 43(3):105-10. PubMed ID: 7037757
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of depressive symptoms with a high concentration hypericum preparation. A multicenter placebo-controlled double-blind study].
Witte B; Harrer G; Kaptan T; Podzuweit H; Schmidt U
Fortschr Med; 1995 Oct; 113(28):404-8. PubMed ID: 7498868
[TBL] [Abstract][Full Text] [Related]
14. [Flunarizine in the treatment of arteriopathies of the legs].
Catalano M; Sacchi E; Tomasini M; Coazzoli E; Parolini A; Dall'Oglio A; Libretti A
Ric Clin Lab; 1985; 15 Suppl 1():475-8. PubMed ID: 4035228
[TBL] [Abstract][Full Text] [Related]
15. [Flunarizine in the therapy of chronic cerebrovascular insufficiency. Multicentric controlled study].
Arrigo A; Lottici P; Alfonsi E; Terraneo GB
Clin Ter; 1984 Sep; 110(6):541-8. PubMed ID: 6238768
[No Abstract] [Full Text] [Related]
16. [Paroxetine in the treatment of depression in geriatric patients--a double-blind comparative study with fluoxetine].
Schöne W; Ludwig M
Fortschr Neurol Psychiatr; 1994 Sep; 62 Suppl 1():16-8. PubMed ID: 7959520
[TBL] [Abstract][Full Text] [Related]
17. The effectiveness of carbamazepine in unipolar depression: a double-blind, randomized, placebo-controlled study.
Zhang ZJ; Tan QR; Tong Y; Li Q; Kang WH; Zhen XC; Post RM
J Affect Disord; 2008 Jul; 109(1-2):91-7. PubMed ID: 18093662
[TBL] [Abstract][Full Text] [Related]
18. The beneficial effects of the herbal medicine Free and Easy Wanderer Plus (FEWP) for mood disorders: double-blind, placebo-controlled studies.
Zhang ZJ; Kang WH; Li Q; Tan QR
J Psychiatr Res; 2007 Nov; 41(10):828-36. PubMed ID: 17010995
[TBL] [Abstract][Full Text] [Related]
19. Comparison of flunarizine (Sibelium) and pizotifen (Sandomigran) in migraine treatment: a double-blind study.
Louis P; Spierings EL
Cephalalgia; 1982 Dec; 2(4):197-203. PubMed ID: 6760980
[TBL] [Abstract][Full Text] [Related]
20. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.
Fruehwald S; Gatterbauer E; Rehak P; Baumhackl U
J Neurol; 2003 Mar; 250(3):347-51. PubMed ID: 12638027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
